Division of Endocrinology, Weill Cornell Medicine, New York, NY.
Department of Integrative Physiology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Hepatology. 2020 Aug;72(2):742-752. doi: 10.1002/hep.31296.
Thyroid hormone (TH) plays a critical role in maintaining metabolic homeostasis throughout life. It is well known that the liver and thyroid are intimately linked, with TH playing important roles in de novo lipogenesis, beta-oxidation (fatty acid oxidation), cholesterol metabolism, and carbohydrate metabolism. Indeed, patients with hypothyroidism have abnormal lipid panels with higher levels of low-density lipoprotein levels, triglycerides (triacylglycerol; TAG), and apolipoprotein B levels. Even in euthyroid patients, lower serum-free thyroxine levels are associated with higher total cholesterol levels, LDL, and TAG levels. In addition to abnormal serum lipids, the risk of nonalcoholic fatty liver disease (NAFLD) increases with lower free thyroxine levels. As free thyroxine rises, the risk of NAFLD is reduced. This has led to numerous animal studies and clinical trials investigating TH analogs and TH receptor agonists as potential therapies for NAFLD and hyperlipidemia. Thus, TH plays an important role in maintaining hepatic homeostasis, and this continues to be an important area of study. A review of TH action and TH actions on the liver will be presented here.
甲状腺激素(TH)在维持生命过程中的代谢稳态中起着至关重要的作用。众所周知,肝脏和甲状腺密切相关,TH 在从头合成脂肪、β-氧化(脂肪酸氧化)、胆固醇代谢和碳水化合物代谢中发挥着重要作用。事实上,甲状腺功能减退症患者的血脂谱异常,表现为低密度脂蛋白(LDL)、甘油三酯(TAG)和载脂蛋白 B 水平升高。即使在甲状腺功能正常的患者中,血清游离甲状腺素水平降低也与总胆固醇、LDL 和 TAG 水平升高有关。除了血清脂质异常外,非酒精性脂肪性肝病(NAFLD)的风险随着游离甲状腺素水平的降低而增加。随着游离甲状腺素的升高,NAFLD 的风险降低。这导致了许多动物研究和临床试验,研究 TH 类似物和 TH 受体激动剂作为治疗 NAFLD 和高脂血症的潜在疗法。因此,TH 在维持肝脏稳态中起着重要作用,这仍然是一个重要的研究领域。本文将综述 TH 的作用及其对肝脏的作用。